| Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. | |
| | |
MedLine Citation:
|
PMID: 21571151 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Stroke is a major cause of death and disability worldwide. Without improvements in prevention, the burden will increase during the next 20 years because of the ageing population, especially in developing countries. Major advances have occurred in secondary prevention during the past three decades, which demonstrate the broader potential to prevent stroke. We review the main medical treatments that should be considered for most patients with transient ischaemic attack or ischaemic stroke in the acute phase and the long term, and draw attention to recent developments. |
| | |
Authors:
|
Peter M Rothwell; Ale Algra; Pierre Amarenco |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Lancet Volume: 377 ISSN: 1474-547X ISO Abbreviation: Lancet Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985213R Medline TA: Lancet Country: England |
Other Details:
|
Languages: eng Pagination: 1681-92 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Stroke Prevention Research Unit, Department of Clinical Neurology, University of Oxford, Oxford, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, control...
Next Document: Stroke rehabilitation.